Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B461- Rhinocerebral mucormycosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Age 18 years of age and above with or without Diabetes Mellitus. 2) Participants diagnosed with covid-19 and being hospitalized and undergoing treatment for the same for the prospective group. 3) Participants who have been deemed clinically recovered from COVID 19 and discharged up to 28 days prior to the commencement of participant recruitment for the retrospective group
Exclusion criteria
Exclusion criteria: Participants who have succumbed to COVID-19 during the duration of study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To screen for Rhino Cerebral Mucormycosis and study the incidence of the same in patients with COVID 19. Timepoint: To screen for Rhino Cerebral Mucormycosis and study the incidence of the same in patients with COVID 19 at 2 weeks, 4 weeks and 6 weeks after discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| To detect Rhino Cerebral Mucormycosis prior to the clinical onset of the disease in these cases using cytological, histopathological and microbiological methods. Timepoint: at 2 weeks, 4 weeks and 6 weeks after discharge.;To study Post covid cases for development of ROCM within 4 weeks of discharge from the hospitalTimepoint: at 2 weeks, 4 weeks and 6 weeks after discharge.;To study the correlation of Pharmacotherapy with Steroids, Immunomodulator drugs, Oxygen Supplementation and Antibiotics for COVID-19 with the relative risk of development of Rhino Cerebral Mucormycosis in these patients. Timepoint: at 2 weeks, 4 weeks and 6 weeks after discharge.;To study the incidence of Rhino Cerebral Mucormycosis in moderate to severe covid cases hospitalized for the management of COVID 19.Timepoint: at 2 weeks, 4 weeks and 6 weeks after discharge. | — |
Countries
India
Contacts
MGM Dental College and Hospital Navi Mumbai